Профилактика венозных тромбоэмболических осложнений у беременных с варикозным расширением вен малого таза

The use of 600 mg phlebodia in pregnant women with varicose veins of the pelvis is pathogenically grounded and effective. The reduction of the main clinical manifestations of this pathology in combination with the stabilization of the disturbed parameters of the blood coagulation system made it possible to prevent such formidable complications of pregnancy as venous thromboembolic complications in pregnant women at high risk